Literature DB >> 19301659

Emergence of a complex relationship between HIV-1 and the microRNA pathway.

Dominique L Ouellet1, Isabelle Plante, Corinne Barat, Michel J Tremblay, Patrick Provost.   

Abstract

Recent experimental evidences support the existence of an increasingly complex and multifaceted interaction between viruses and the microRNA-guided RNA silencing machinery of human cells. The discovery of small interfering RNAs (siRNAs), which are designed to mediate cleavage of specific messenger RNAs (mRNAs), prompted virologists to establish therapeutic strategies based on siRNAs with the aim to suppress replication of several viruses, including human immunodeficiency virus type 1 (HIV-1). It has been appreciated only recently that viral RNAs can also be processed endogenously by the microRNA-generating enzyme Dicer or recognized by cellular miRNAs, in processes that could be viewed as an adapted antiviral defense mechanism. Known to repress mRNA translation through recognition of specific binding sites usually located in their 3' untranslated region, miRNAs of host or viral origin may exert regulatory effects towards host and/or viral genes and influence viral replication and/or the host response to viral infection. This article summarizes our current state of knowledge on the relationship between HIV-1 and miRNA-guided RNA silencing, and discusses the different aspects of their interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301659      PMCID: PMC2911478          DOI: 10.1007/978-1-60327-547-7_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  107 in total

1.  Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants.

Authors:  Leath A Tonkin; Brenda L Bass
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

2.  The small RNA profile during Drosophila melanogaster development.

Authors:  Alexei A Aravin; Mariana Lagos-Quintana; Abdullah Yalcin; Mihaela Zavolan; Debora Marks; Ben Snyder; Terry Gaasterland; Jutta Meyer; Thomas Tuschl
Journal:  Dev Cell       Date:  2003-08       Impact factor: 12.270

3.  Multiple secondary structure rearrangements during HIV-1 RNA dimerization.

Authors:  Hendrik Huthoff; Ben Berkhout
Journal:  Biochemistry       Date:  2002-08-20       Impact factor: 3.162

4.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

Review 5.  Approaches for chemically synthesized siRNA and vector-mediated RNAi.

Authors:  Mohammed Amarzguioui; John J Rossi; Dongho Kim
Journal:  FEBS Lett       Date:  2005-09-20       Impact factor: 4.124

6.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

7.  P-body formation is a consequence, not the cause, of RNA-mediated gene silencing.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Daniel Schweizer; Elisa Izaurralde
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

Review 8.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

9.  SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Authors:  Christopher S Sullivan; Adam T Grundhoff; Satvir Tevethia; James M Pipas; Don Ganem
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

10.  Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.

Authors:  Yamina Bennasser; Shu-Yun Le; Monsef Benkirane; Kuan-Teh Jeang
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

View more
  9 in total

1.  Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients.

Authors:  Martin Torriani; Suman Srinivasa; Kathleen V Fitch; Thomas Thomou; Kimberly Wong; Eva Petrow; C Ronald Kahn; Aaron M Cypess; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2016-01-12       Impact factor: 5.958

2.  miR-190b is markedly upregulated in the intestine in response to simian immunodeficiency virus replication and partly regulates myotubularin-related protein-6 expression.

Authors:  Mahesh Mohan; Lawrance C Chandra; Workineh Torben; Pyone P Aye; Xavier Alvarez; Andrew A Lackner
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 3.  Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system.

Authors:  Patrick M Regan; Rajnish S Dave; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

Review 4.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

Review 5.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

6.  The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference.

Authors:  Madeeha Aqil; Afsar Raza Naqvi; Aalia Shahr Bano; Shahid Jameel
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

7.  Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.

Authors:  Amy M Hayes; Shuiming Qian; Lianbo Yu; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2011-05-13       Impact factor: 4.602

Review 8.  MicroRNAs - Biology and clinical applications.

Authors:  Kannan Ranganathan; Vaishnavi Sivasankar
Journal:  J Oral Maxillofac Pathol       Date:  2014-05

Review 9.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output.

Authors:  Maria Fernanda Pascutti; Martje N Erkelens; Martijn A Nolte
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.